Compare FSV & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSV | LNTH |
|---|---|---|
| Founded | 1988 | 1956 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.6B |
| IPO Year | 2015 | 2014 |
| Metric | FSV | LNTH |
|---|---|---|
| Price | $128.99 | $99.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $208.25 | $87.00 |
| AVG Volume (30 Days) | 189.5K | ★ 852.6K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.91 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $7.49 | N/A |
| Revenue Next Year | $6.79 | $14.19 |
| P/E Ratio | $49.49 | ★ $34.27 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $119.41 | $49.67 |
| 52 Week High | $190.64 | $111.86 |
| Indicator | FSV | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 37.48 | 37.99 |
| Support Level | $122.19 | $98.81 |
| Resistance Level | $146.14 | $101.24 |
| Average True Range (ATR) | 3.41 | 0.43 |
| MACD | -0.45 | -0.04 |
| Stochastic Oscillator | 19.87 | 19.54 |
FirstService Corp is engaged in outsourcing property services. The company operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertaPro Painters, Floor Coverings International, and Pillar to Post Home Inspectors. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.